Clinical Trials on Cocaine Related Disorders in New Zealand

Total 18229 results

Danish Headache Center

Recruiting

Effect of Sumatriptan on Levcromakalim-Induced Symptoms in Individuals With Migraine (SLIM)

Headache | Migraine Without Aura

Denmark
Danish Headache Center

Recruiting

Effect of Ivabradine on Levcromakalim-Induced Symptoms in Individuals With Migraine Without Aura (ILIM) (ILIM)

Headache | Migraine Without Aura

Denmark
Yale University
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Completed

Opioid Use Disorder in the Emergency Department: CTN 0069

Opioid Use Disorder

United States
New York State Psychiatric Institute

Completed

NMDA Antagonists in Bipolar Depression

Bipolar Disorder

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Effectiveness of Lithium and Valproate in Treating High-Risk Bipolar Disorder

Bipolar Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Phase IIa Study of AV411, a Glial Activation Inhibitor, for Opioid Withdrawal (AV411)

Opioid-Related Disorders

United States
Click Therapeutics, Inc.

Completed

Clinical Trial of Smoking Cessation Mobile Phone Program

Substance Use Disorder | Drug Addiction | Tobacco Dependence | Drug Dependence | Nicotine Addiction

United States
Yale University
National Institute on Drug Abuse (NIDA)

Recruiting

Integrated e-Health (Electronic Health) for HIV and Substance Use Disorders in Justice Involved Women

HIV | Opioid Use Disorder | eHealth

United States
RAND
National Institute of Mental Health (NIMH); University of Pittsburgh; Boston... and other collaborators

Active, not recruiting

Collaboration Leading to Addiction Treatment and Recovery From Other Stresses (CLARO)

Depression | Addiction | Opioid-use Disorder | Post-traumatic Stress Disorder

United States
Yale University
VA Office of Research and Development

Recruiting

Examination of Glutamate and mGluR5 in Psychiatric Disorders

Bipolar Disorder | Major Depressive Disorder | Post-Traumatic Stress Disorder

United States
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

New Approaches to Smoking Cessation in Heavy Drinkers

Alcohol Consumption | Nicotine Dependence | Cigarette Smoking | Heavy Drinking

United States
University of New Mexico
National Institute on Drug Abuse (NIDA); University of Michigan; Wake Forest...

Recruiting

Healing Opioid Misuse and Pain Through Engagement (HOPE) Trial (HOPE)

Chronic Pain | Opioid Use Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Active, not recruiting

Facilitating Rapid Naltrexone Initiation

Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone

Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Memantine and Naltrexone Treatment for Opioid Dependence (NAMHS-1)

Opioid Dependence

United States
New York State Psychiatric Institute
Indivior Inc.

Completed

Reinforcing Effects of Intranasal (IN) Buprenorphine Versus Buprenorphine/Naloxone

Heroin Dependence

United States
Hurd,Yasmin, Ph.D.

Completed

Study to Test the Safety and Efficacy of Cannabidiol as a Treatment Intervention for Opioid Relapse

Opiate Addiction

United States
Theranova, L.L.C.

Recruiting

EMPOWER AUD Pivotal Trial

Alcoholism | Alcohol Use Disorder | Alcohol Abuse

United States
Juvenile Bipolar Research Foundation

Terminated

Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder (IKBP)

Bipolar Disorder

United States
Danish Headache Center

Completed

Deep Phenotyping of Rosacea and Migraine

Migraine | Rosacea

Denmark
National Institute on Drug Abuse (NIDA)

Completed

Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2

Tobacco Use Disorder | Schizophrenia and Disorders With Psychotic Features

United States
Montefiore Medical Center
National Institute on Drug Abuse (NIDA)

Terminated

BUPrenorphine Facilitated Access and Supportive Treatment --AIM 3 (BUPFAST)

Opioid-related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA); Mayo Clinic; University of Alabama at... and other collaborators

Completed

Clinical Decision Support to Implement ED-initiated Buprenorphine for OUD (EMBED)

Opioid-use Disorder | Buprenorphine | Clinical Decision Support

United States
Icahn School of Medicine at Mount Sinai

Completed

Cognitive Training for Mood and Anxiety Disorders

Depression | Generalized Anxiety Disorder | Bipolar Disorder | Major Depressive Disorder | Social Phobia | Post-traumatic Stress Disorder

United States
The University of New South Wales

Completed

Remediation of Cognitive Dysfunction in Euthymic Bipolar Disorder Patients Using Transcranial Direct Current Stimulation (tDCS)

Bipolar Disorder

Australia
University of Rochester
Stanley Medical Research Institute

Completed

Omega-3 Fatty Acids in Children and Adolescents With Bipolar Disorder

Bipolar Disorder

United States
Duke University
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH); University at Buffalo

Recruiting

Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings (MTQT)

Schizophrenia | Schizoaffective Disorder | Tobacco Use Disorder | Bipolar Disorder | Mental Illness | Persistent Depressive Disorder | Recurring Major Depressive Disorder

United States
Louisiana State University Health Sciences Center...

Completed

Alcohol & Metabolic Comorbidities in PLWHA: Evidence Driven Interventions (ALIVE-Ex)

HIV/AIDS | Alcohol Use Disorder | Dysglycemia

United States
Boehringer Ingelheim

Completed

Pharmacokinetics and Pharmacodynamics Trial With Linagliptin (BI 1356) 5mg in African American Type 2 Diabetic Patients

Diabetes Mellitus, Type 2

United States
New York State Psychiatric Institute
Alkermes, Inc.

Terminated

Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals

Heroin Dependence

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA); University of California, Los Angeles and other collaborators

Completed

Extended-Release Naltrexone Opioid Treatment at Jail Re-Entry (XOR)

Opioid-Related Disorders | Heroin Dependence

United States
NYU Langone Health

Withdrawn

Needle-X: Usability Testing of a Smartphone Application

Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Glutamatergic Modulation to Facilitate Naltrexone Initiation in Opioid Dependence

Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Dronabinol Naltrexone Treatment for Opioid Dependence (Domino)

Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Improved Strategies for Outpatient Opioid Detoxification

Opioid Dependence

United States
National Institute on Drug Abuse (NIDA)
New York MDRU

Completed

Buprenorphine and Naloxone Combination Study - 10

Opioid-Related Disorders | Heroin Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance for Opioid Addicts - 1

Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Withdrawn

Neurobiology of Opioid Dependence: 4 - 4

Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Withdrawn

Neurobiology of Opioid Dependence: 1 - 1

Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Effectiveness of Lofexidine to Prevent Stress-Related Opiate Relapse During Naltrexone Treatment - 1

Opioid-Related Disorders

United States
Yale University
National Cancer Institute (NCI)

Active, not recruiting

A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV (SMARTTT)

Tobacco Use Cessation

United States
University of New Mexico
Patient-Centered Outcomes Research Institute; Montana State University; National... and other collaborators

Terminated

Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies

Bipolar Disorder

United States
Dartmouth-Hitchcock Medical Center
Dartmouth College; Children's Bureau - Administration for Children and Families and other collaborators

Recruiting

Wraparound for High-risk Families With Substance Use Disorders: Examining Family, Child, and Parent Outcomes

Substance-Related Disorders | Depression | Child Abuse | Stress Disorders, Post-Traumatic | Child Neglect

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Memantine as a Supplement to Naltrexone in Treating Heroin Dependence (NAMHS)

Heroin Dependence | Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone (Depot-BNT)

Heroin Dependence | Opiate Dependence

United States
National Institute on Drug Abuse (NIDA)

Completed

A Preliminary Study of Sustained-Release Bupropion for Smoking Cessation in Bipolar Affective Disorder

Bipolar Disorder

United States
Click Therapeutics, Inc.

Completed

Clinical Learning Study for a Mobile Smoking Cessation Program

Smoking | Smoking Cessation | Smoking Reduction | Nicotine Dependence | Smoking, Cigarette | Smoking Behaviors

United States
University of Rochester
National Institute on Drug Abuse (NIDA)

Completed

Virtual Clinician Research Tool (VCRT)

Tobacco Dependence | Elevated Risk of Cardiovascular Disease

United States
New York State Psychiatric Institute

Completed

Tranylcypromine Treatment of Bipolar Depression

Bipolar Disorder I or II

United States
NYU Langone Health

Terminated

Brain Ion Homeostasis, Lithium and Bipolar Disorder

Healthy | Bipolar Disorder

United States

Clinical Trials on Cocaine Related Disorders in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations